European regulators greenlight Fractyl Health's clinical test of GLP-1 gene therapy

Harith Rajagopalan, Fractyl Health CEO May 11, 2026 07:00 AM EDT R&DCell/Gene Tx Eu­ro­pean reg­u­la­tors green­light first clin­i­cal test of GLP-1 gene ther­a­py Ryan Cross Senior Science Correspondent Drug de­vel­op­ers are rac­ing to make gene ther­a­pies that could re­place chron­ic GLP-1 in­jec­tions and pills with a one-and-done treat­ment. Now, a … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER